Prof. Dr. Salvatore De-Simone | Nanobiotechnology Awards | Best Researcher Award

Prof. Dr. Salvatore De-Simone | Nanobiotechnology Awards | Best Researcher Award

Prof. Dr. Salvatore De-Simone ,Oswaldo Cruz Institute (IOC),Brazil

Salvatore Giovanni De Simone is a prominent biochemist with a distinguished career in the fields of biotechnology, molecular biology, and infectious diseases. He earned his Bachelor of Science in Biomedical Sciences from the State of Rio de Janeiro University (1976), followed by a Master’s (1980) and Doctorate (1986) in Biochemistry from the Federal University of Rio de Janeiro. Throughout his career, Dr. De Simone has held various prestigious positions, including Full Professor of Biochemistry at the Federal Fluminense University and Chief of the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute (FIOCRUZ). He has also served as a visiting researcher at several renowned international institutions. Currently, Dr. De Simone is a Specialist in Science and Technology Production and Innovation in Health at the Oswaldo Cruz Foundation and a member of the National Institute of Neglected Population Diseases of Brazil. His research focuses on antimicrobial peptides, protein structure, and immunological diagnostics, and he has published extensively on these topics. Dr. De Simone has supervised numerous graduate students and postdoctoral researchers and has coordinated significant national and international research projects and symposiums.

Professional Profile:

Scopus

Orcid

Suitability for the “Best Researcher Award” – Summary and Conclusion

Candidate: Salvatore Giovanni De Simone

Summary of Suitability: Salvatore Giovanni De Simone is an accomplished scientist with an extensive background in biochemistry, molecular biology, and infectious diseases. His career spans over four decades, highlighted by significant contributions to academia, research, and scientific innovation. De Simone has held prestigious positions, including Full Professor of Biochemistry at the Federal Fluminense University and Chief of the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute. His work has led to numerous advancements in understanding and combating infectious diseases, particularly through the study of protein structures, antimicrobial peptides, and the development of diagnostic tools.

šŸŽ“Education:

Salvatore Giovanni De Simone holds a Bachelor of Science in Biomedical Sciences from the State of Rio de Janeiro University, completed in 1976. He further advanced his education by earning a Master of Science in Biochemistry in 1980, followed by a Doctor of Science in Biochemistry in 1986, both from the Federal University of Rio de Janeiro

šŸ¢Work Experience:

Salvatore Giovanni De Simone has held numerous prestigious positions throughout his career. He is currently a Specialist in Science and Technology Production and Innovation in Health at the Center for Technological Development in Health (CDTS) at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Previously, he served as a Full Professor of Biochemistry at the Federal Fluminense University in NiterĆ³i, Rio de Janeiro, from 1984 to 2012. He also led the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute (FIOCRUZ) from 1992 to 2012. In addition to his roles in Brazil, Dr. De Simone has gained international experience as a Visiting Researcher at the Laboratory of Genic Recombination at the Institut d’Hematologie-Centre Hayem, Hopital St. Louis in Paris, France, in 1987; at the Department of Medical Parasitology at New York University (NYU) in the United States from 1988 to 1989; and at the European Molecular Biology Laboratory (EMBL) in Germany in 1990.

šŸ…Awards and Honors:

Salvatore Giovanni De Simone has been recognized with several notable awards and positions throughout his career. He has received the Researcher Productivity Award (Category 1C) from the National Council of Scientific and Technological Development (CNPq) in Brazil and has been honored as a Scientist of the State of Rio de Janeiro by the Foundation for Research Support of the State of Rio de Janeiro (FAPERJ). Dr. De Simone also coordinated the Peptide Synthesis Platform at the Oswaldo Cruz Foundation from 1992 to 2012. Additionally, he served as a member of the Assessment Committee in Biotechnology for the National Council of Research from Brazil (CNPq) during the 2022-2023 term.

Publication Top Notes:

  • Title: Development of an Electrochemical Immunosensor for the Diagnostic Testing of Spotted Fever Using Synthetic Peptides
    • Citations: 18
  • Title: Cryptosporidium spp. Contamination in Perna perna Mussels Destined for Human Consumption in Southeastern Rio de Janeiro, Brazil
    • Citations: 7
  • Title: Ultrasensitive and Rapid Immuno-detection of Human IgE Anti-therapeutic Horse Sera Using an Electrochemical Immunosensor
    • Citations: 9
  • Title: Development of an ELISA for the Diagnosis of Reactive IgE Antibodies Anti-therapeutic Horse Sera
    • Citations: 10
  • Title: Oligopeptidase B and B2: Comparative Modelling and Virtual Screening as Searching Tools for New Antileishmanial Compounds
    • Citations: 11

 

 

 

 

Assist. Prof. Dr. Israa M.S. Al-Kadmy | Nanobiotechnology Awards | Women Researcher Award

Assist. Prof. Dr. Israa M.S. Al-Kadmy | Nanobiotechnology Awards | Women Researcher Award

Assist. Prof. Dr. Israa M.S. Al-Kadmy ,Al-Mustansiriya University \ College of Science \ Department of Life Sciences , Iraq

Israa Mohammed Safa Abd Ali AL-Kadmy, born on November 30, 1984, in Baghdad, Iraq, is an accomplished researcher and academic in the fields of microbiology and nanotechnology. She earned her BSc in Biology and an MSc in Microbiology from Mustansiriyah University, Iraq. Her academic career includes positions as Assistant Lecturer, Lecturer, and Assistant Professor at various institutions, with a focus on biotechnology, molecular biology, and nanobiotechnology. She has been a Visiting Academic at Plymouth University and has taught courses at Queenā€™s University Belfast, Lancaster University, and Teesside University. Her research interests include molecular microbiology, nano-biotechnology, and graphene-based biosensors. Dr. AL-Kadmy is actively involved in numerous professional societies and has participated in various international conferences. She is dedicated to advancing the field of nanomaterials and their applications in health care and environmental sustainability.

Professional Profile:

Scopus

Orcid

Summary of Suitability for the Research for Women Researcher Award

Candidate: Israa Mohammed Safa Abd Ali Al-Kadmy

Israa Al-Kadmy’s dedication to advancing nanobiotechnology, her comprehensive teaching and research experience, and her active involvement in scientific communities make her an exemplary candidate for the Research for Women Researcher Award. Her work not only contributes to scientific knowledge but also has practical implications for healthcare and biosensor technologies. Her achievements in a challenging field, combined with her active engagement in both academic and charitable activities, highlight her as a leading female researcher making a meaningful impact in her domain.

šŸŽ“Education:

Israa Mohammed Safa Abd Ali AL-Kadmy completed her undergraduate studies with a Bachelor of Science in Biology from Mustansiriyah University, College of Science, Iraq, in 2006. She pursued her postgraduate education at the same institution, earning a Master of Science in Microbiology in 2012. Her MSc thesis focused on the “Detection of 16S rRNA Methylation Gene between Two Species of Gram Negative with High-Level Resistance to Aminoglycosides,” reflecting her deep engagement with molecular microbiology and resistance mechanisms

šŸ¢Work Experience:

Israa Mohammed Safa Abd Ali AL-Kadmy has held several notable academic and research positions across prestigious institutions. She has been an Assistant Professor at Mustansiriyah University, Iraq, since May 2020. Prior to this, she served as a Lecturer at Teesside University, UK, from October 2021 to September 2022, where she taught modules on Sustainability in Chemical Engineering and Environmental and Sustainable Processing. She is currently a Lecturer in Chemical Engineering at Lancaster University, UK, starting in September 2022, where she covers Hydrogen and Fuel Cell Technologies and Chemical Process Design Project

šŸ†Awards and Honors:

Israa Mohammed Safa Abd Ali AL-Kadmy is an active member of several esteemed professional societies. She is affiliated with the Biological Organization Iraqis, the Science and Engineering Institute (SCIEI), and the Iraqi Society of Nanotechnology STAF ID. Her involvement extends to the International Society for Development and Sustainability (ISDS), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Global Research & Development Services (GRDS). Additionally, she is a member of the European Biosafety Association (EBSA), the British Ecological Society (BES), the Microbiological Society in Europe, and the British Society for Immunology (BSI). Her participation in these organizations underscores her commitment to advancing research and development in her fields of expertise.

Publication Top Notes:

  • Sequencing Analysis and Efficient Biodiesel Production by Lipase from Pseudomonas aeruginosa
    Citations: 1
  • “The Secrets of Environmental Pseudomonas aeruginosa in Slaughterhouses: Antibiogram Profile, Virulence, and Antibiotic Resistance Genes”
    Citations: 1
  • “The Predominance of Virulence Genes Associated with Multidrug-Resistant Serratia marcescens Isolated from Urinary Tract Infections”
  • “Reducing Environmental Pollutants of Chicken Feathers by Production and Biodegradation of the Chicken Feather Keratinase from Aspergillus niger and Its Role as the Anti-biofilm Activity”
  • “COVID-19 Associated Mucormycosis Among ICU Patients: Risk Factors, Control, and Challenges”

 

 

 

 

Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Dr. Priyanka Singh , Denmark Technical University , Denmark

Dr. Priyanka Singh is a Senior Researcher at the Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark. With over seven years of post-doctoral experience, she specializes in green nanoscience and medical biology, focusing on innovative drug development for cancer and infections. Dr. Singh holds a Ph.D. in Nanoscience from Kyung Hee University and has secured substantial external funding for her pioneering research in nanomaterials. She is also committed to mentoring Ph.D. students and fostering interdisciplinary collaborations to advance cell biology and translate research into impactful outcomes.

Professional Profile:

Google Scholar

Education:

Dr. Priyanka Singh earned her Ph.D. in Nanoscience from Kyung Hee University, South Korea, in 2016, where she designed nanoparticles and drug conjugates/nanoformulations to enhance the pharmacokinetics of poorly water-soluble drugs for cancer and infectious cells. She holds a Diploma in Transformational Leadership Programme-Leading Women from CBS, Denmark, completed in November 2020. Dr. Singh has acquired several certifications from the University of Wisconsinā€“Madison, USA, including physiological characterization, solubilization, and solid form screening for drugs (2022), biologics (2021), drug development processes and CMC aspects (2021), and preclinical and phase 1 oral drug formulations (2021). Additionally, she completed a Teaching Lab course at DTU in January 2022, focused on university-level teaching and learning. Her academic background also includes a Masterā€™s in Microbiology from CSJMU, India (2008-2010), and a Bachelorā€™s in Microbiology from Kachchh University, India (2005-2008).

Work Experience:

Dr. Priyanka Singh is a Senior Researcher at the Center for Biosustainability, Technical University of Denmark, since December 2023. She leads studies on developing nanomaterials for anticancer and antimicrobial drugs, publishing in high-impact journals, and supervises Ph.D. students in hands-on development of these materials. She is also leading a project on ā€œgraphene-based solutions for marine biofilm inhibitionā€ and employs advanced techniques like Flow cytometry, SEM, TEM, and Incucyte for characterizing nanomaterials in various disease models. From January 2021 to November 2023, as a Researcher at the same center, she led a team advancing nanomaterials in medical applications, focusing on biologics formation and characterization, investigating their impact on cancer cells, and enhancing their therapeutic potential.

Publication TopĀ  Notes: